Dangerous Drug and Consumer Product Information

RxWatch provides dangerous drug, over-the-counter-medications and consumer products including FDA Warnings and important medical studies as well as information about litigation regarding these products.

RxWatch is constantly monitoring drug safety alerts, FDA Warnings and major medical journals to stay on top of the latest vital safety information for pharmaceuticals, over the counter medications and other consumer products so that we may alert you as quickly as possible after dangerous side effects and serious medical risks become known. In most cases, these dangerous drugs remain on the market and continue to be used by millions of unsuspecting Americans.

Below are pharmaceuticals, over the counter medications and other consumer products that RxWatch is most concerned about. Over 100 million Americans use these products, all of which have been the focus of alarming medical studies

Talcum Powder Ovarian Cancer

Research since the 1970's has demonstrated an increase in the risk of ovarian cancer from using talcum powder products for feminine hygiene. Numerous medical studies have concluded that feminine dusting with talcum powder increases the ovarian cancer risk by as much as 41%. Onder Law recently won a $72 million verdict against Johnson & Johnson. Read the RxWatch Talcum Powder Alert

Nexium/Prilosec/Prevacid

Proton pump inhibitors, one requiring a prescription but now available over the counter, are some of the most widely used medications in the world for treating conditions such as heartburn and acid refult. They are now being considered as one of the most over-prescribed medications in the world and may have increased the risk of Chronic Kidney Disease by 50%. Read the RxWatch Nexium/Prilosec/Prevacid Alert

Levaquin

This antibiotic is routinely used to treat respiratory and urinary tract infections. Recent medical reports show an increase in aortic injuries, specifically aortic aneurysm and aortic dissection, both of which can rupture, creating a life-threatening medical emergency. This warning applies to both past and current Levaquin usage. Read the RxWatch Levaquin Alert

Onglyza and Kombiglize XR

These Type 2 diabetes medications use saxagliptin to control blood glucose without causing weight gain. However, Onglyza and Kombiglyze XR have now received FDA Warnings after being linked to an increased risk of heart failure in a significant medical study published in the New England Journal of Medicine. Read the RxWatch Onglyza/Kombiglyze XR Alert

Xarelto

Xarelto is a blood thinner used to prevent blood clots, which can prevent stroke, pulmonary embolism, deep vein thrombosis and related medical conditions. It has been linked to a risk of internal bleeding, which has resulted in death in some patients. Read the RxWatch Xarelto Alert

Invokana

This is a Type 2 diabetes drug manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. It initially received fast-track approval, but medical studies now show Invokana may cause diabetic ketoacidosis, kidney failure, cardiac problems, even death. Read the RxWatch Invokana Alert